» Articles » PMID: 9620781

Genetic Mapping of a Second Myotonic Dystrophy Locus

Overview
Journal Nat Genet
Specialty Genetics
Date 1998 Jun 10
PMID 9620781
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

We report the mapping of a second myotonic dystrophy locus, myotonic dystrophy type 2 (DM2). Myotonic dystrophy (DM) is a multi-system disease and the most common form of muscular dystrophy in adults. In 1992, DM was shown to be caused by an expanded CTG repeat in the 3' untranslated region of the dystrophia myotonica-protein kinase gene (DMPK) on chromosome 19 (refs 2-6). Although several theories have been put forth to explain how the CTG expansion causes the broad spectrum of clinical features associated with DM, it is not understood how this mutation, which does not alter the protein-coding region of a gene, causes an affect at the cellular level. We have identified a five-generation family (MN1) with a genetically distinct form of myotonic dystrophy. Affected members exhibit remarkable clinical similarity to DM (myotonia, proximal and distal limb weakness, frontal balding, cataracts and cardiac arrhythmias) but do not have the chromosome-19 D CTG expansion. We have mapped the disease locus (DM2) of the MN1 family to a 10-cM region of chromosome 3q. Understanding the common molecular features of two different forms of the disease should shed light on the mechanisms responsible for the broad constellation of seemingly unrelated clinical features present in both diseases.

Citing Articles

Cognitive impairment, neuroimaging abnormalities, and their correlations in myotonic dystrophy: a comprehensive review.

Wu Y, Wei Q, Lin J, Shang H, Ou R Front Cell Neurosci. 2024; 18:1369332.

PMID: 38638300 PMC: 11024338. DOI: 10.3389/fncel.2024.1369332.


Ultra-widefield imaging and peripheral optical coherence tomography of peripheral reticular pigmentary degeneration (PRPD) in myotonic dystrophy.

Banerjee M, Venkatesh P, Azad S BMJ Case Rep. 2023; 16(11).

PMID: 38035686 PMC: 10689402. DOI: 10.1136/bcr-2023-258173.


Parent-of-Origin Effect on the Age at Symptom Onset in Myotonic Dystrophy Type 2.

Gonzalez-Perez P, DAmbrosio E, Picher-Martel V, Chuang K, David W, Amato A Neurol Genet. 2023; 9(3):e200073.

PMID: 37123986 PMC: 10136683. DOI: 10.1212/NXG.0000000000200073.


Associations between lower extremity muscle fat fraction and motor performance in myotonic dystrophy type 2: A pilot study.

Madrid D, Knapp R, Lynch D, Clemens P, Weaver A, Puwanant A Muscle Nerve. 2023; 67(6):506-514.

PMID: 36938823 PMC: 10898809. DOI: 10.1002/mus.27821.


A Greek National Cross-Sectional Study on Myotonic Dystrophies.

Papadimas G, Papadopoulos C, Kekou K, Kartanou C, Kladi A, Nitsa E Int J Mol Sci. 2022; 23(24).

PMID: 36555146 PMC: 9778724. DOI: 10.3390/ijms232415507.